Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12102680 Anti-TIGIT antibodies

Patent 12102680 was granted and assigned to Merck Sharp & Dohme Limited on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Merck Sharp & Dohme Limited

0

Current Assignee

Merck Sharp & Dohme Limited

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Gopalan Raghunathan0

Sybil M. G. Williams0

Laurence Fayadat-Dilman0

Wolfgang Seghezzi0

Drake LaFace0

Linda Liang0

Date of Patent

October 1, 2024

0

Patent Application Number

168066580

Date Filed

May 15, 2020

0

Patent Citations

US Patent 8968750 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other C2-domain containing proteins

0

US Patent 7193069 Full-length cDNA

0

US Patent 7368527 HADDE71 polypeptides

0

US Patent 10618958 Anti-TIGIT antibodies

0

Patent Primary Examiner

0

Patent abstract

The present invention relates to anti-TIGIT antibodies, as well as use of these antibodies in the treatment of diseases such as cancer and infectious disease.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12102680 Anti-TIGIT antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool